Research/art/teacher profile of a person
Name and surname:
doc. Mgr. Jana Jurečeková, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Jurečeková
I.2 - Name
Jana
I.3 - Degrees
doc. Mgr., PhD.
I.4 - Year of birth
1983
I.5 - Name of the workplace
Department of Medical Biochemistry JFM CU
I.6 - Address of the workplace
Mala Hora 4D, 03601 Martin
I.7 - Position
associate professor
I.8 - E-mail address
jurecekova1@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/5191
I.10 - Name of the study field in which a person works at the university
General Medicine
I.11 - ORCID iD
0000-0002-1743-5137

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences CU
II.b - Year
2007
II.c - Study field and programme
Biology-chemistry
II.3 - Third degree of higher education
II.a - Name of the university or institution
Jessenius Faculty of Medicine CU
II.b - Year
2011
II.c - Study field and programme
Medical, Clinical and Pharmaceutical Biochemistry
II.4 - Associate professor
II.b - Year
2025
II.c - Study field and programme
Medical, Clinical and Pharmaceutical Biochemistry
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
researcher Jessenius Faculty of Medicine CU 16.1.2012 - 31.10.2015
researcher Jessenius Faculty of Medicine CU 1.12.2015 - 31.10.2018
assistant professor Jessenius Faculty of Medicine CU 1.11.2018 - 31.12.2025
associate proffesor Jessenius Faculty of Medicine CU since 1.1.2026

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Essentials of Oncology for the monitors of the clinical trials NEOX Academy 2010
Masterclass in scientific writing and publishing, Excellent Science Days 2.0 Workshop Wroclaw Academic Hub, Poland 2017

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Medical Chemistry General Medicine I.+II. General Medicine
Medical Biochemistry 1 General Medicine I.+II. General Medicine
Medical Biochemistry 2 General Medicine I.+II. General Medicine
Medical Chemistry for Dental Medicine Dentistry, Dental Medicine I.+II. Dentistry, Dental Medicine
Medical Biochemistry for Dental Medicine Dentistry, Dental Medicine I.+II. Dentistry, Dental Medicine
Dentistry, Dental Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
0
V.4.c - Dissertation (third degree)
1
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
1
V.4.c - Dissertation (third degree)
0
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
156
VI.1.b - Over the last six years
48
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
32
VI.1.b - Over the last six years
11
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
236
VI.1.b - Over the last six years
149
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
219
VI.1.b - Over the last six years
163
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
0
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

Jurečeková, Jana - Kmeťová Sivoňová, Monika - Evinová, Andrea - Kliment, Ján - Dobrota, Dušan: The association between estrogen receptor alpha polymorphisms and the risk of prostate cancer in Slovak population. In: Molecular and Cellular Biochemistry. - Roč. 381, č. 1-2 (2013), s. 201-207. - ISSN 0300-8177; IF (JCR) 2013=2,388; Citations (10)

2

Jurečeková, Jana - Babušíková, Eva - Kmeťová Sivoňová, Monika - Drobková, Henrieta - Petráš, Martin - Kliment, Ján - Halašová, Erika : Association between interleukin-18 variants and prostate cancer in Slovak population. In: Neoplasma. - Roč. 64, č. 1 (2017), s. 148-155. - ISSN (print) 0028-2685, registered in: wos, scopus, IF (JCR) 2017=1,696; Citations (13)

3

Jurečeková, Jana - Babušíková, Eva - Kmeťová Sivoňová, Monika - Kliment, Ján - Dobrota, Dušan: Estrogen receptor alpha polymorphisms and the risk of prostate cancer development. In: Journal of Cancer Research and Clinical Oncology. - Roč. 141, č. 11 (2015), s. 1963-1971. - ISSN 0171-5216; Registered in: wos, scopus; IF (JCR) 2015=3,141; Citations (6)

4

Jurečeková, Jana - Blahušiak Drobková, Henrieta - Šarlinová, Miroslava - Babušíková, Eva - Kmeťová Sivoňová, Monika - Matáková, Tatiana - Kliment, Ján - Halašová, Erika: The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression [elektronický dokument]. In: Anticancer Research [elektronický dokument]. - Roč. 38, č. 6 (2018), s. 3663-3667 [print]. - ISSN (print) 0250-7005, Registered in: scopus, wos; IF (JCR) 2018=1,935; scimago-sjr -- Q2 [Medicine (miscellaneous)] -- 2018; Citattions (7)

5

Kmeťová Sivoňová, Monika - Kaplán, Peter - Tatarková, Zuzana - Lichardusová, Lucia - Dušenka, Róbert - Jurečeková, Jana: Androgen receptor and soy isoflavones in prostate cancer. In: Molecular and Clinical Oncology. - Roč. 10, č. 2 (2019), s. 191-204. - ISSN (print) 2049-9450; registered in: wos, scopus; scimago-sjr -- Q4 [Cancer research] -- 2019, Citations (40)

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Evin D, Evinová A, Baranovičová E, Šarlinová M, Jurečeková J, Kaplán P, Poláček H, Halašová E, Dušenka R, Briš L, Brožová MK, Sivoňová MK. Integrative Metabolomic Analysis of Serum and Selected Serum Exosomal microRNA in Metastatic Castration-Resistant Prostate Cancer. Int J Mol Sci. 2024 Feb 23;25(5):2630. wos, scopus, IF (JCR) 2022= 5.6; Citations (3)

2

Mečiaková M, Kmeťová Sivoňová M, Vondrák A, Evin D, Knoško Brožová M, Kliment J, Dobrota D, Jurečeková J. Association between the aromatase rs2411096 polymorphism and prostate cancer. Bratislava Medical Journal 2025; 126(2):149-155. registrované v: wos, scopus, JIF (Medicine, general & internal) - Q2

3

Kmeťová Sivoňová, Monika - Tatarková, Zuzana - Jurečeková, Jana - Kliment, Ján - Híveš, Mark - Lichardusová, Lucia - Kaplán, Peter : Differential profiling of prostate tumors versus benign prostatic tissues by using a 2DE-MALDI-TOF-based proteomic approach In: Neoplasma. - Roč. 68, č. 1 (2021), s. 154-164. - ISSN (print) 0028-2685, IF (JCR) 2021=3.409, scimago-sjr -- Q2 [Medicine (miscellaneous)] -- 2021, citations (9)

4

Jurečeková, Jana - Kmeťová Sivoňová, Monika - Blahušiak Drobková, Henrieta - Híveš, Mark - Evin, Daniel - Kliment, Ján- Dobrota, Dušan : Association between estrogen receptor beta polymorphisms and prostate cancer in a Slovak population. Oncology Letters.- Roč. 21, č. 3 (2021)– ISSN 1792-1074. IF: 3.111 - 2021, JIF - Oncology - Q3, citations (3)

5

Vilčková, Marta - Škereňová, Mária - Dobrota, Dušan - Kaplán, Peter - Jurečeková, Jana - Kliment, Ján - Híveš, Mark - Dušenka, Róbert - Evin, Daniel - Knoško Brožová, Martina - Kmeťová Sivoňová, Monika: Polymorphisms in the gene encoding CYP1A2 influence prostate cancer risk and progression. Oncology Letters, Roč. 25, č. 2 (2023), IF: 2.5 - 2023, JCI - Oncology - Q3

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

2016 - Rahman, H. P. - Hofland, J. - Foster, P. A. In touch with your feminine side: How oestrogen metabolism impacts prostate cancer. DOI 10.1530/ERC-16-0118 In: Endocrine-Related Cancer, 2016, Roč. 23, č. 6, s. R249-R266. - SCIE; SCO; WOS CC; CCC, s. R249 - R266; IF: 5,267 – 2016; Kvartil Q (2016): JIF - Oncology – Q1

ADC_006 / Jurečeková, Jana (Autor) [UKOLJ111] (60%) - Babušíková, Eva (Autor) [UKOLJ111] (20%) - Kmeťová Sivoňová, Monika (Autor) [UKOLJ111] (10%) - Kliment, Ján (Autor) [UKOLJ151] (5%) - Dobrota, Dušan (Autor) [UKOLJ111] (5%): Estrogen receptor alpha polymorphisms and the risk of prostate cancer development.– DOI 10.1007/s00432-015-1966-6. – CCC; SCO; WOS CC; BIOSIS Citation Index; MEDLINE®; SCIE.

In: Journal of cancer research and clinical oncology [textový dokument (print)] [elektronický dokument] : official organ of the Deutsche Krebsgesellschaft. – New York (USA): Springer Nature. Springer International Publishing AG. – ISSN 0171-5216. – ISSN (online) 1432-1335. – Roč. 141, č. 11 (2015), s. 1963-1971

2

2023 [01/20] / GBR - Wu, F. - Wang, M. - Zhong, T. - Xiao, C. - Chen, X. - Huang, Y. - Wu, M. - Yu, J. - Chen, D. Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer [elektronický dokument] In: Experimental hematology and oncology. Londýn: Springer Nature. BioMed Central, 2023, Roč. 12, č. 1, [online]. ISSN (online) 2162-3619. - SCIE ; SCO ; WOS CC; IF: 9,4 – 2023; Kvartil Q (2023): JIF - Oncology – Q1

ADD_004 / Jurečeková, Jana (Autor) [UKOLJ111] (50%) - Babušíková, Eva (Autor) [UKOLJ111] (20%) - Kmeťová Sivoňová, Monika (Autor) [UKOLJ111] (5%) - Blahušiak Drobková, Henrieta (Autor) [Interný doktorand] [UKOLJ151] (10%) - Petráš, Martin (Autor) [UKOLJ110A] (5%) - Kliment, Ján (Autor) [UKOLJ151] (5%) - Halašová, Erika (Autor) [UKOLJ120] (5%): Association between interleukin-18 variants and prostate cancer in Slovak population. – text. – DOI 10.4149/neo_2017_119. – CCC ; SCO ; WOS CC ; MEDLINE® ; BIOSIS Citation Index ; SCIE.

In: Neoplasma [textový dokument (print)] [elektronický dokument]. – Bratislava (Slovensko) : Academic Electronic Press. – ISSN 0028-2685. – ISSN (online) 1338-4317. – Roč. 64, č. 1 (2017), s. 148-155

3

2020 [01/12] / CHE - Gomes dos Santos, A. - Watanabe, E. H. - Ferreira, D. T. - Oliveira, J. - Nakanishi, É. S. - Oliveira, C. S. - Bocchi, E. - Novaes, C. T. G. - Cruz, F. - Carvalho, N. B. - Sato, P. K. - Yamashiro-Kanashiro, E. H. - Pontillo, A. - de Freitas, V. L. T. - Onuchic, L. F. - Shikanai-Yasuda, M. A. Článok [elektronický dokument] In: Frontiers in immunology. Lausanne: Frontiers Media, 2020, Roč. 11, č. 521409, [online]. ISSN (online) 1664-3224. - SCIE; SCO; WOS CC; IF: 7,561 – 2020; Kvartil Q (2020): JIF - Immunology – Q1

ADD_004 / Jurečeková, Jana (Autor) [UKOLJ111] (50%) - Babušíková, Eva (Autor) [UKOLJ111] (20%) - Kmeťová Sivoňová, Monika (Autor) [UKOLJ111] (5%) - Blahušiak Drobková, Henrieta (Autor) [Interný doktorand] [UKOLJ151] (10%) - Petráš, Martin (Autor) [UKOLJ110A] (5%) - Kliment, Ján (Autor) [UKOLJ151] (5%) - Halašová, Erika (Autor) [UKOLJ120] (5%): Association between interleukin-18 variants and prostate cancer in Slovak population. – text. – DOI 10.4149/neo_2017_119. – CCC ; SCO ; WOS CC ; MEDLINE® ; BIOSIS Citation Index ; SCIE.

In: Neoplasma [textový dokument (print)] [elektronický dokument]. – Bratislava (Slovensko): Academic Electronic Press. – ISSN 0028-2685. – ISSN (online) 1338-4317. – Roč. 64, č. 1 (2017), s. 148-155

4

2022 [01/20] / GBR - He, Y. - Xu, W. - Xiao, Y. T. - Huang, H. - Gu, D. - Ren, S. Článok [elektronický dokument] In: Signal transduction and targeted therapy. [Londýn] : Springer Nature. Nature Publishing Group, 2022, Roč. 7, č. 1, [tlačená forma] [online]. ISSN 2095-9907. ISSN (online) 2059-3635. - SCIE ; SCO ; WOS CC; IF: 39,3 – 2022; Kvartil Q (2022): JIF - Biochemistry & Molecular biology – Q1

ADD_005 / Kmeťová Sivoňová, Monika (Autor) [UKOLJ111] (60%) - Jurečeková, Jana (Autor) [UKOLJ111] (15%) - Tatarková, Zuzana (Autor) [UKOLJ111] (5%) - Kaplán, Peter (Autor) [UKOLJ111] (5%) - Lichardusová, Lucia (Autor) [UKOLJ110B] (5%) - Hatok, Jozef (Autor) [UKOLJ111] (10%): The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition. – text. – DOI 10.4149/gpb_2017024. – CCC ; SCO ; WOS CC ; BIOSIS Citation Index ; MEDLINE® ; SCIE.

In: General physiology and biophysics [textový dokument (print)] [elektronický dokument] . – Bratislava (Slovensko) : Slovenská akadémia vied. Centrum biovied. Ústav molekulárnej fyziológie a genetiky. – ISSN 0231-5882. – ISSN (online) 1338-4325. – Roč. 36, č. 5 (2017), s. 487-499

5

2020 [01/12] / DEU - Gatenby, R. A. - Brown, J. S. Článok [elektronický dokument] In: Nature Reviews Clinical Oncology. Berlin: Springer Nature. Springer. Nature Portfolio, 2020, Roč. 17, č. 11, [tlačená forma] [online]. ISSN 1759-4774. ISSN (online) 1759-4782. - SCIE ; SCO ; WOS CC, s. 675 – 686; IF: 66,675 – 2020; Kvartil Q (2020): JIF - Oncology – Q1

ADD_005 / Kmeťová Sivoňová, Monika (Autor) [UKOLJ111] (60%) - Jurečeková, Jana (Autor) [UKOLJ111] (15%) - Tatarková, Zuzana (Autor) [UKOLJ111] (5%) - Kaplán, Peter (Autor) [UKOLJ111] (5%) - Lichardusová, Lucia (Autor) [UKOLJ110B] (5%) - Hatok, Jozef (Autor) [UKOLJ111] (10%): The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition. – text. – DOI 10.4149/gpb_2017024. – CCC ; SCO ; WOS CC ; BIOSIS Citation Index ; MEDLINE® ; SCIE.

In: General physiology and biophysics [textový dokument (print)] [elektronický dokument] . – Bratislava (Slovensko) : Slovenská akadémia vied. Centrum biovied. Ústav molekulárnej fyziológie a genetiky. – ISSN 0231-5882. – ISSN (online) 1338-4325. – Roč. 36, č. 5 (2017), s. 487-499

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

The role of genetic and epigenetic changes in estrogen receptor pathway in prostate cancer development and progression. Project VEGA 1/271/19. Realization: 2019-2022, principal investigator

2

 Identification of potentially new diagnostic and prognostic biomarkers of prostate cancer by mass spectrometry-based proteomics. Project VEGA 1/172/18. Realization: 2018-2021, investigator

3

The molecular mechanisms of the statins effect on inhibition, proliferation and differentiation of selected stem and tumour cells and their application in regenerative medicine. Project APVV-0217-15. Realization: 2016-2020, investigator

4

The role of the genetic variants in G1/S transition-related genes of cell cycle in the development of prostate cancer, VEGA 1/0014/22, 2022-2025, investigator

5

Analysis of the association molecular changes in the membrane sex hormones receptors with the risk of the development and progression of prostate cancer. VEGA 1/0065/25, 2025-2028, principal investigator

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Medical College of Wisconsin 8701 Watertown Plank Road, Milwaukee, WI 53226-0509 8.8.2011-31.10.2011 study stay paid by the Fund of the Comenius University in Bratisalava

IX. - Other relevant facts

Date of last update
2026-02-06